Dr. Joseph A. Ball

Schar Chair, Advanced Lung Disease and Lung Transplant Medical Director, Advanced Lung Disease and Lung Transplant Program, Inova Schar Heart and Vascular Professor of Medical Education, University of Virginia, Inova CampusSteven D. Nathan, MD, FCCP, is the medical director of Inova’s Advanced Lung Disease Program and Lung Transplant Program. He is also a professor of medicine at the University of Virginia.Dr. Nathan is board certified in pulmonary diseases, critical care medicine and internal medicine. The author of more than 500 publications, Dr. Nathan is internationally recognized for his expertise in advanced lung diseases. He is co-editor of two books on idiopathic pulmonary fibrosis that provide pulmonologists and other healthcare workers with an up-to-date review of the background and advances in the field: Idiopathic Pulmonary Fibrosis and Guide to Clinical Management of Idiopathic Pulmonary Fibrosis. He also has written original research manuscripts, abstracts, reviews and book chapters. Dr. Nathan is a reviewer for multiple journals and is on the editorial board for the journal, Thorax. He has served on multiple committees, including U.S. Food and Drug Administration advisory boards as well as steering committees for clinical trials in IPF and pulmonary hypertension, where he has also served as chair. Dr. Nathan is a member of several professional medical associations, including the American Thoracic Society, the American College of Chest Physicians, and the International Society for Heart and Lung Transplantation. He has delivered talks and been chairperson of numerous sessions at many national and international conferences. Dr. Nathan is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Idiopathic Pulmonary Fibrosis, Acute Interstitial Pneumonia, Interstitial Lung Disease, Lung Transplant, and Prostatectomy. Dr. Nathan is currently accepting new patients.

Dr. Sonye Danoff, MD is a Pulmonologist in Baltimore, MD and has over 29 years of experience in the medical field. Dr. Danoff has extensive experience in Obstructive Lung Disease and Sleep Apnea. She graduated from Johns Hopkins School of Medicine in 1993. She is affiliated with medical facilities Johns Hopkins Bayview Medical Center and The Johns Hopkins Hospital. Dr. Danoff is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Interstitial Lung Disease, Acute Interstitial Pneumonia, Pulmonary Fibrosis, Endoscopy, and Lung Transplant. Dr. Danoff is board certified in American Board Of Internal Medicine (Pulmonary Disease) (1999).

Whitney Brown, MD, is director of Clinical Operations and medical director of the Cystic Fibrosis and Bronchiectasis Program at Inova Advanced Lung Disease and Transplant Program at Inova Fairfax Hospital. Dr. Brown has been with the Inova Advanced Lung Disease and Transplant Program since 2010. She is board certified in pulmonary disease, critical care medicine and internal medicine Dr. Brown has a special interest in idiopathic pulmonary fibrosis (IPF), lung transplant outcomes and the care of adult cystic fibrosis patients. She enjoys conducting outcomes-based research and has co-authored two original research articles on IPF, one on prognosis in IPF and the other on the impact of hospitalization on IPF. Dr. Brown is a member of the American Thoracic Society and the International Society for Heart and Lung Transplantation. Dr. Brown is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Acute Interstitial Pneumonia, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Lung Transplant, and Endoscopy. Dr. Brown is currently accepting new patients.